After two strong years driven by the global pandemic, the German life sciences industry did not perform as well in terms of equity investment in 2022. As Biotechgate data shows, venture investment in biotech companies fell by almost half as compared to 2021, and with only USD 419 million in equity funding, is at its … Continue reading Germany Life Science Trend Analysis 2023
Category: Life Sciences Reports
This area includes the yearly life sciences and Biotech reports with statistics retrieved from Biotechgate.
Taiwan Life Science Trend Analysis 2023
The biotech industry is one of Taiwan’s key industries that the Taiwanese government is actively promoting with the aim of strengthening international partnerships and growing export services. According to Biotechgate data, biotech companies account for 41% (263) of the total 640 life science companies in Taiwan. As for most other countries, the pandemic boosted the … Continue reading Taiwan Life Science Trend Analysis 2023
South Korea Life Science Trend Analysis 2022
In 2021, biotech companies account for 44% of the life sciences companies in South Korea. More than half of South Korean biotechs are part of the therapeutics and diagnostics sector, of which 19% are publicly listed on the stock exchange. The total value of venture financing for South Korean life sciences companies dropped by around … Continue reading South Korea Life Science Trend Analysis 2022
Maryland Life Science Trend Analysis 2022
The life science industry in Maryland shows an upward trend in 2021, with an increase of 41% in private equity investment value of life science companies compared to the previous year. While there were 11 private equity rounds of biotech companies with a total investment of USD 302 million in 2020, the number of rounds … Continue reading Maryland Life Science Trend Analysis 2022
Netherlands Life Science Trend Analysis 2022 – Time to Focus on Knowledge Transfer for Dutch Life Sciences Sector
Tuesday, 31 May 2022 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2022 of the Dutch life sciences sector. In 2021 compared to 2020, new biotech companies grew with 2% and the amount of products in development in the (pre-)clinical phase increased with 22%. Although there is an increasing trend for … Continue reading Netherlands Life Science Trend Analysis 2022 – Time to Focus on Knowledge Transfer for Dutch Life Sciences Sector
Canada Life Science Trend Analysis 2022
In 2021, both Canadian and foreign investors closed overall larger venture capital deals than ever, resulting in an increasingly robust life science industry in Canada. In the Biotech – Therapeutics and Diagnostics sector alone, the three top financing deals were each worth at least 100 million USD. For more details on the Biotechgate data, see … Continue reading Canada Life Science Trend Analysis 2022
Denmark Life Science Trend Analysis 2022
The Danish life science industry continued its upward trend in 2021, reflecting the ongoing high priority of this industry for Denmark. While the number of biotech private equity financing rounds of 17 is as high as the previous year, a record amount of venture capital was raised in 2021, partly thanks to an exceptionally large … Continue reading Denmark Life Science Trend Analysis 2022
France Life Science Trend Analysis 2022
2021 was a year of exceptional growth for the life science industry in France. In particular, biotech venture financing boomed in the second half of 2021 with a record USD 706 million in investment raised. Biotechgate data indicates a focus on on R&D services for the French biotech industry, being the largest biotech sector with … Continue reading France Life Science Trend Analysis 2022
Switzerland Life Science Trend Analysis 2022
As Biotechgate data shows, private equity investment rounds of life science companies increased by around 35% in 2021 compared to 2020. Despite venture investments in biotech companies declining slightly in 2021 compared to the strong previous annum, it was still a solid year for the biotech industry in Switzerland. Four of the five biotech companies … Continue reading Switzerland Life Science Trend Analysis 2022
United Kingdom Life Science Trend Analysis 2022
2021 was another record year for investments into UK life science companies.With a continued focus on tackling the COVID-19 pandemic, there was a remarkable increase in both the size and number of private financings compared to previous years. According to Biotechgate data for 2021, a record USD 3,138 million in venture capital was invested into … Continue reading United Kingdom Life Science Trend Analysis 2022